Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Oxygenta Pharmaceutical Ltd.

Oxygenta Pharma

₹ 0.00

0.00 (0.00)%

Healthcare

Small-cap - With a market cap of ₹1.95 Cr.

EX-Date	Purpose
30 06 2021	Audited Results
12 08 2021	Quarterly Results
15 11 2021	Quarterly Results
14 02 2022	Quarterly Results
20 05 2022	Audited Results
12 08 2022	Quarterly Results
12 11 2022	Quarterly Results
14 02 2023	Quarterly Results
27 02 2023	Preferential Issue of shares & Increase in Authorised Capital & Inter-alia, to consider and approve: 1. Raising of funds by way of issue of Securities (both equity and warrants) on preferential basis as per the Regulation of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with Companies Act, 2013 and rules made thereunder. 2. Conversion of unsecured loan into equity shares through preferential issue as per the Regulation of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with Companies Act, 2013 and rules made thereunder. 3. Other corporate/ incidental matters.
30 05 2023	Audited Results
14 08 2023	Quarterly Results
14 11 2023	Quarterly Results
14 02 2024	Quarterly Results
08 04 2024	Inter-alia, to consider and approve: 1. Raising of funds by way of issue of Equity Shares on preferential basis as per the Regulation of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with Companies Act, 2013 and rules made thereunder. 2. Other corporate/ incidental matters.
14 11 2024	Quarterly Results
14 02 2025	Quarterly Results
30 05 2025	Audited Results
14 08 2025	Quarterly Results
07 11 2025	Quarterly Results
04 02 2026	Quarterly Results
23 05 2026	Audited Results
25 07 2026	Quarterly Results
27 07 2026	Quarterly Results (Revised)

News

No News data available